Loading clinical trials...
Loading clinical trials...
Safety, Immunogenicity, Infectivity, and Dose-Finding Study of an Investigational Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccine in Infants and Toddlers
Conditions
Interventions
RSV vaccine formulation 1
RSV vaccine formulation 2
+1 more
Locations
29
United States
Matrix Clinical Research-Site Number:8400012
Gardena, California, United States
Paradigm Clinical Research-Site Number:8400026
La Mesa, California, United States
Matrix Clinical Research-Site Number:8400032
Los Angeles, California, United States
California Research Foundation-Site Number:8400016
San Diego, California, United States
Elite Clinical Trials, Inc.-Site Number:8400001
Blackfoot, Idaho, United States
Leavitt Clinical Research-Site Number:8400036
Idaho Falls, Idaho, United States
Start Date
September 17, 2020
Primary Completion Date
April 13, 2023
Completion Date
April 13, 2023
Last Updated
September 9, 2025
NCT07220109
NCT07092865
NCT07239583
NCT04732871
NCT06534892
NCT06546800
Lead Sponsor
Sanofi Pasteur, a Sanofi Company
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions